EXACT Therapeutics: Correction of final warrants exercise date

Oslo, Norway, 5 February 2026. Reference is made to the stock exchange announcement by EXACT Therapeutics AS (the "Company", Euronext Growth ticker: EXTX), a clinical-stage precision medicine company, published at 09:17 today on 5 February 2026. In the earlier announcement, it was incorrectly stated that the remaining warrants holders may exercise their warrants within 21 February 2026. The correct final date for the warrants exercise is 26 February 2026.

About EXACT Therapeutics: EXACT Therapeutics is a clinical-stage precision medicine company utilizing the power of ultrasound to activate the proprietary drug PS101 and enhance the clinical benefit of oncology therapies. PS101 has a unique mode of action and may be combined with a wide range of therapeutic agents within oncology and across a multitude of other indications, including brain diseases. EXACT Therapeutics’ shares are traded on Euronext Growth Oslo (EXTX). Further information may be found here:www.exact-tx.com

For further information, please contact: Per Walday CEO EXACT Therapeutics Email: per.walday@exact-tx.com